NGS Reagent Kit
Delivery Restriction
This product cannot be shipped to your selected delivery address/country. Purchase has been disabled.
Product Information
Product Description
The AVENIO ctDNA Expanded Kit V2 is a next-generation sequencing (NGS) liquid biopsy research assay with a 77 gene panel containing genes in U.S. National Comprehensive Cancer Network (NCCN) Guidelines1 and emerging cancer biomarkers. It is a pan-cancer assay that’s specially optimized for lung cancer and colorectal cancer (CRC) research.
Features and Benefits
Contains genes in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines1 and emerging cancer biomarkers
All four mutation classes (SNVs, indels, fusions and CNVs) in a single assay
Exceptional analytical performance supported by integrated digital error suppression (iDES) strategies combining molecular barcodes with in silico error suppression techniques2,3
Includes reagents, bioinformatics and software
Streamlined, end-to-end research workflow from extraction to analysis and reporting in five days
Additional Information
- • Seller Company: Roche Sequencing
- • Stock Status: In Stock
- • VAT Rate: %20
- • Delivery Status: Select address for delivery eligibility.
